Profile
Sector:
HealthcareCountry:
United StatesIPO:
12 November 2021Website:
http://journeymedicalcorp.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:08:34 GMTDividend
Analysts recommendations
Institutional Ownership
DERM Latest News
Journey Medical Corporation (NASDAQ: DERM) will be hosting its Q1 2024 Earnings Conference Call on May 14, 2024 at 4:30 PM ET. Presenters include Jaclyn Jaffe, Claude Maraoui, Joseph Benesch, Dr. Srinivas Sidgiddi, and Ramsey Allous. Conference call participants include Scott Henry, Kalpit, and others. Thank you for joining us.
Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
Journey Medical (DERM) stock rises as the FDA accepts its regulatory filing for review seeking approval for DFD-29 to treat inflammatory lesions and erythema of rosacea in adults.
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET
Novo Nordisk (NVO), Journey Medical Corporation (DERM), Lyra Therapeutics (LYRA) and Fusion Pharmaceuticals (FUSN) have returned 40% or higher year to date and have room for more growth in 2024.
Here, we discuss some reasons why investing in Journey Medical (DERM) stock now may turn out to be a prudent move.
WING, JAKK, NSIT, GIII and DERM are five stocks with explosive relative price strength.
Does Journey Medical Corporation (DERM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Journey Medical Corporation (DERM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Journey Medical Corporation (NASDAQ:DERM ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Interim Chief Financial Officer Dr. Srinivas Sidgiddi - Vice President, Research and Development Ramsey Allous - General Counsel and Corporate Secretary Conference Call Participants Scott Henry - ROTH Capital Andy Fleszar - B. Riley Operator Ladies and gentlemen, thank you for standing by.
- 1(current)
What type of business is Journey Medical?
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
What sector is Journey Medical in?
Journey Medical is in the Healthcare sector
What industry is Journey Medical in?
Journey Medical is in the Drug Manufacturers - Specialty & Generic industry
What country is Journey Medical from?
Journey Medical is headquartered in United States
When did Journey Medical go public?
Journey Medical initial public offering (IPO) was on 12 November 2021
What is Journey Medical website?
https://journeymedicalcorp.com
Is Journey Medical in the S&P 500?
No, Journey Medical is not included in the S&P 500 index
Is Journey Medical in the NASDAQ 100?
No, Journey Medical is not included in the NASDAQ 100 index
Is Journey Medical in the Dow Jones?
No, Journey Medical is not included in the Dow Jones index
When does Journey Medical report earnings?
The next expected earnings date for Journey Medical is 08 August 2024